Adaptive Biotechnologies Corporation
← Back to ADPT Overview

Adaptive Biotechnologies Corporation (ADPT)

Solvency & Capital Structure

Total Debt

$410.5M

Net Debt

$66.2M

Adaptive Biotechnologies Corporation currently has $410.5M in total debt. Net debt is $66.2M after cash offsets.

Financial Fundamentals

ADPTQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-06-300.410.340.070.6464.1%
2026-03-310.210.22-0.01Net Cash0.5141.1%
2025-12-310.280.230.050.5154.7%
2025-09-300.080.21-0.13Net Cash0.4916.7%
2025-06-300.080.20-0.11Net Cash0.5017.0%
2025-03-310.090.19-0.11Net Cash0.5117.0%
2024-12-310.090.22-0.13Net Cash0.5416.6%
2024-09-300.090.24-0.15Net Cash0.5616.4%
2024-06-300.090.29-0.20Net Cash0.5816.1%
2024-03-310.100.31-0.21Net Cash0.6215.6%
2023-12-310.100.35-0.25Net Cash0.6614.9%
2023-09-300.100.37-0.27Net Cash0.7214.1%
2023-06-300.100.42-0.31Net Cash0.7613.5%
2023-03-310.110.44-0.33Net Cash0.7913.4%
2022-12-310.110.50-0.39Net Cash0.8612.6%
2022-09-300.110.51-0.40Net Cash0.8812.3%
2022-06-300.110.38-0.27Net Cash0.8113.8%
2022-03-310.110.36-0.25Net Cash0.8613.2%
2021-12-310.110.35-0.24Net Cash0.9212.1%
2021-09-300.110.42-0.30Net Cash0.9911.4%
2021-06-300.110.60-0.49Net Cash1.0310.5%
2021-03-310.100.71-0.61Net Cash1.079.3%
2020-12-310.110.69-0.58Net Cash1.129.7%
2020-09-300.050.84-0.79Net Cash1.104.2%
2020-06-300.050.57-0.52Net Cash0.855.3%
2020-03-310.040.56-0.52Net Cash0.874.3%
2019-12-310.040.58-0.54Net Cash0.914.0%
2019-09-300.020.57-0.55Net Cash0.922.6%
2019-06-300.000.42-0.42Net Cash0.600.0%
2019-03-310.000.44-0.44Net Cash0.610.0%
2018-12-310.000.17-0.17Net Cash0.330.0%
2018-03-310.000.19-0.19Net Cash0.00